93 related articles for article (PubMed ID: 25771729)
21. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas.
Soung YH; Lee JW; Nam SW; Lee JY; Yoo NJ; Lee SH
Oncology; 2006; 70(4):285-9. PubMed ID: 17047397
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
[TBL] [Abstract][Full Text] [Related]
24. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
[TBL] [Abstract][Full Text] [Related]
25. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
Shi J; Yao D; Liu W; Wang N; Lv H; Zhang G; Ji M; Xu L; He N; Shi B; Hou P
BMC Cancer; 2012 Feb; 12():50. PubMed ID: 22292935
[TBL] [Abstract][Full Text] [Related]
26. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
28. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
[TBL] [Abstract][Full Text] [Related]
29. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
30. Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.
Harlé A; Lion M; Lozano N; Husson M; Harter V; Genin P; Merlin JL
Oncol Rep; 2013 Mar; 29(3):1043-52. PubMed ID: 23314198
[TBL] [Abstract][Full Text] [Related]
31. Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Qi L; Sun K; Zhuang Y; Yang J; Chen J
J BUON; 2017; 22(6):1488-1493. PubMed ID: 29332342
[TBL] [Abstract][Full Text] [Related]
32. Mutation of the PIK3CA gene in ovarian and breast cancer.
Campbell IG; Russell SE; Choong DY; Montgomery KG; Ciavarella ML; Hooi CS; Cristiano BE; Pearson RB; Phillips WA
Cancer Res; 2004 Nov; 64(21):7678-81. PubMed ID: 15520168
[TBL] [Abstract][Full Text] [Related]
33. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.
Jiang G; Huang Z; Zhang S; Wang L
Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208
[TBL] [Abstract][Full Text] [Related]
34. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk.
Ge Y; Liu H; Qiu X; Ma G; Wang H; Du M; Wang M; Zhao Q; Tao G; Chu H; Zhang Z
Gene; 2018 Sep; 670():130-135. PubMed ID: 29802999
[TBL] [Abstract][Full Text] [Related]
36. PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.
Kalinsky K; Heguy A; Bhanot UK; Patil S; Moynahan ME
Breast Cancer Res Treat; 2011 Sep; 129(2):635-43. PubMed ID: 21617917
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
Harada K; Baba Y; Shigaki H; Ishimoto T; Miyake K; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwatsuki M; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
BMC Cancer; 2016 Jul; 16():400. PubMed ID: 27388016
[TBL] [Abstract][Full Text] [Related]
38. Mutations of PIK3CA in gastric adenocarcinoma.
Li VS; Wong CW; Chan TL; Chan AS; Zhao W; Chu KM; So S; Chen X; Yuen ST; Leung SY
BMC Cancer; 2005 Mar; 5():29. PubMed ID: 15784156
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.
Shah S; Shah S; Padh H; Kalia K
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):628-35. PubMed ID: 26453385
[TBL] [Abstract][Full Text] [Related]
40. Molecular spectrum of PIK3CA gene mutations in patients with nonsmall-cell lung cancer in Turkey.
Ekinci S; Ilgin-Ruhi H; Dogan M; Gursoy S; Dizbay-Sak S; Demirkazik A; Tukun A
Genet Test Mol Biomarkers; 2015 Jul; 19(7):353-8. PubMed ID: 26053643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
